Classifying interval cancers as false negatives or newly occurring in fecal immunochemical testing.
Wen-Feng HsuChen-Yang HsuAmy Ming-Fang YenSam Li-Sheng ChenSherry Yueh-Hsia ChiuJean Ching-Yuan FannYi-Chia LeeHan-Mo ChiuTony Hsiu-Hsi ChenPublished in: Journal of medical screening (2021)
Newly developed colorectal cancers showed a predominance among the FIT interval colorectal cancers in particular in the younger population screened. It is desirable to identify high-risk individuals to offer them a short interscreening interval or advanced detection methods to reduce their odds of developing interval cancer.